GLP-1 patients will also find a curated assortment of beneficial vitamins and minerals such as vitamin B6, iron, vitamin D3+K2, magnesium and folate to help replenish any nutrient deficiencies caused by a reduced intake of fortified and animal source foods
Taking 1mg finasteride once a day is proven to stop hair loss and can even regrow hair [3-4]
GLP-1 timeline: what to expect month by month Month 1: Getting started Target: 2-3% of your starting weight lost You'll notice reduced hunger and cravings quite quickly Energy may dip slightly as your body adjusts Some people experience mild nausea or digestive changes Month 2: Finding your rhythm Target: 4-5% total weight loss from baseline Hunger control becomes more consistent Side effects typically settle down You might increase to your first stable dose around now Month 3: Building momentum Target: 5-8% total weight loss from baseline Clothes fit differently, even if the scales slow down Energy levels start to improve New habits are beginning to stick Months 4-6: Steady progress Month 6 target: 10-15% total loss Weight loss continues at a steady, sustainable pace You're likely settled into a stable dose that's working well Focus on maintaining muscle through protein and activity Months 6-12: Consolidation Month 12 target: 15-20% total weight loss from baseline Progress may slow but remains consistent Body composition changes become really noticeable Many people reach their target weight or body composition goal Your dose might stay the same for months at a time Beyond 12 months: Maintenance You may stay on medication long-term or transition to a maintenance dose The goal shifts to keeping weight off, not losing indefinitely Regular check-ins help you adjust your approach as needed Some people step down to a lower dose while maintaining their results Which GLP-1 weight loss injections are avaliable
With FDA-cleared treatments and expert medical care, you can start your transformation today.
Innovative triple-combination pill designed to improve blood pressure control earlier in treatment
doi:10.1136/bmjopen-2022-061807 25
